When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 22 Hits
  • Search Condition : Filter (MeSH = Receptor, ErbB-2 / genetics)
Species Resource Title
Human and Animal Cells EBC-1(RCB1965) Met-HER3 crosstalk supports proliferation via MPZL3 in MET-amplified cancer cells.
Human and Animal Cells MKN45(RCB1001) , MKN74(RCB1002) , MKN7(RCB0999) , HuG1-N(RCB1179) Apoptosis signal-regulating kinase-1 inhibitor as a potent therapeutic drug for the treatment of gastric cancer.
Human and Animal Cells Lu99(RCB1900) , PC-9(RCB4455) Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinoma.
Human and Animal Cells A549 , LC-2/ad(RCB0440) , RERF-LC-KJ(RCB1313) PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer.
Human and Animal Cells PC-9(RCB4455) Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14-mutant Non-small Cell Lung Cancer.
Human and Animal Cells HuCCT1(RCB1960) , TFK-1(RCB2537) Therapeutic implication of HER2 in advanced biliary tract cancer.
Human and Animal Cells KE-39(RCB1434) , KE-97(RCB1435) Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer.
Human and Animal Cells G-415(RCB2640) , TGBC1TKB(RCB1129) , TGBC2TKB(RCB1130) Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.
Human and Animal Cells HeLa Design Strategy to Create Antibody Mimetics Harbouring Immobilised Complementarity Determining Region Peptides for Practical Use.
Human and Animal Cells CW-2(RCB0778) Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.
Human and Animal Cells Ba/F3(RCB0805) Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study.
Human and Animal Cells MKN7(RCB0999) , A431 Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
Human and Animal Cells RPMI1788(RCB1878) Detection of Her2-overexpressing cancer cells using keyhole shaped chamber array employing a magnetic droplet-handling system.
Human and Animal Cells DU145(RCB2143) Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathway.
Human and Animal Cells CW-2(RCB0778) Overcoming resistance to HER2 inhibitors through state-specific kinase binding.
Human and Animal Cells YSCCC(RCB1549) , TGBC1TKB(RCB1129) , TGBC2TKB(RCB1130) , TGBC14TKB(RCB1186) Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.
Human and Animal Cells MCF7(RCB1904) p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors.
Human and Animal Cells MKN28(RCB1000) , MKN74(RCB1002) Lysophospholipids transactivate HER2/neu (erbB-2) in human gastric cancer cells.
Human and Animal Cells HBL-100(RCB0460) Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas.
Human and Animal Cells HHUA(RCB0658) CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.